
Exciting news! HAMLET BioPharma has signed a Letter of Intent with a German uro-oncology partner on a potential collaboration for Alpha1H in bladder cancer. Alpha1H has FDA Fast Track and clearance for a pivotal Phase III study. 🧬🤝 Read more: spotlightstockmarket.com/sv/…


